| Full Name | Andrea Delucia |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 21 Doreen Dr, Avenel, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164115598 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 37LC00364000 (New Jersey) | Secondary |
| 1041C0700X | Social Worker - Clinical | 44SC06160400 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Delucia, 21 Doreen Dr, Avenel, NJ 07001-1505 Ph: (908) 625-3400 | Andrea Delucia, 21 Doreen Dr, Avenel, NJ 07001-1505 Ph: (908) 625-3400 |
News Archive
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis compared with similar adults who do not have cancer during the same period, according to a report published online today in Blood. Lung and colon cancers, as well as advanced-staged cancers, appear to be most strongly associated with an elevated risk of heart attack and stroke caused by blood clots in the arteries.
"Health ministers from the Association of Southeast Asian Nations (ASEAN) are being asked to support United Nations efforts to stem the spread of drug-resistant strains of malaria, especially along the borders of Cambodia and Burma," VOA News reports.
The Children's Hospital of Philadelphia achieved high rankings in the annual information technology (IT) rankings announced this week by the industry publication InformationWeek. The Hospital ranked among both the top 10 innovators in the healthcare industry, and on the list of Top 20 Great Ideas, for defining and streamlining clinicians' access to electronic health records, while keeping those records secure.
Tianyin Pharmaceutical Co., Inc.,, a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce Pediatric Fever and Cough Oral Liquid in dosage form of 10 ml/tube (SFDA approval number Z20093060) and Antibacterial and Anti-inflammatory Capsules in dosage form of 0.27 gram/capsule (SFDA approval number Z20090855).
At various points in our lives, we're curious about our health risks, wondering about our susceptibility for everything from high cholesterol to a deadly inherited disease. We might want to learn more about our risks when we reach a certain age or experience a bout of bad health; when we hear about a friend or co-worker coping with a dreaded illness; or read the latest headlines about disease research.
› Verified 7 days ago